MedTrace Logo

Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study

NCT03026790 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 820

Last updated 2023-06-05

Study results available
· View outcomes & findings →

Summary

Background and significance: Treatment with opioid pain medications (like hydrocodone and morphine) is common for severe pain, but studies show these medications may not always help and can cause serious problems. High daily doses of opioids can be especially unsafe. To help patients with chronic pain have better quality of life and avoid medication toxicity, health care teams need to manage pain while helping patients reduce opioid medication doses to safer levels.

Conditions

Interventions

OTHER

Medication management

Individualized management of medications for pain

OTHER

Non-pharmacological pain management

Individualized management of non-medication pain treatment approaches

DRUG

Buprenorphine-Naloxone

Option of using buprenorphine-naloxone to assist with opioid dose reduction or discontinuation

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-19
Primary Completion
2022-03-17
Completion
2022-10-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03026790 on ClinicalTrials.gov